Devalued and distrusted : can the pharmaceutical industry restore its broken image? /

Devalued and distrusted : can the pharmaceutical industry restore its broken image? / / John L. LaMattina.

"While the pharmaceutical industry can play an important role in converting the knowledge generated by the Human Genome Project into new medicines, it also faces a popular perception that it is simply out to make money by promoting unsafe medicines to an unsuspecting public. Written by former P...

Full description

Saved in:
Bibliographic Details
:
ProQuest (Firm)
LaMattina, John L.
TeilnehmendeR:
ProQuest (Firm)
Year of Publication:2013
Language:English
Online Access:
Physical Description:ix, 125 p. :; col. ill.
Tags: Add Tag
No Tags, Be the first to tag this record!
id 5001104475
ctrlnum (MiAaPQ)5001104475
(Au-PeEL)EBL1104475
(CaPaEBR)ebr10641813
(CaONFJC)MIL422992
(OCoLC)823389919
collection bib_alma
record_format marc
spelling LaMattina, John L.
Devalued and distrusted [electronic resource] : can the pharmaceutical industry restore its broken image? / John L. LaMattina.
Hoboken, N.J. : Wiley, 2013.
ix, 125 p. : col. ill.
Includes bibliographical references and index.
Machine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts.
"While the pharmaceutical industry can play an important role in converting the knowledge generated by the Human Genome Project into new medicines, it also faces a popular perception that it is simply out to make money by promoting unsafe medicines to an unsuspecting public. Written by former Pfizer president John LaMattina, this book addresses the progress that the industry has made in improving its abilities to measure both the risk and benefits of its new medicines, where the industry should invest its R&D resources, and how the industry can rehabilitate its image. Essential reading for pharmaceutical executives and professionals"-- Provided by publisher.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
Pharmaceutical industry Corrupt practices.
Electronic books.
ProQuest (Firm)
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1104475 Click to View
language English
format Electronic
eBook
author LaMattina, John L.
spellingShingle LaMattina, John L.
Devalued and distrusted can the pharmaceutical industry restore its broken image? /
Machine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts.
author_facet LaMattina, John L.
ProQuest (Firm)
ProQuest (Firm)
author_variant j l l jl jll
author2 ProQuest (Firm)
author2_role TeilnehmendeR
author_corporate ProQuest (Firm)
author_sort LaMattina, John L.
title Devalued and distrusted can the pharmaceutical industry restore its broken image? /
title_sub can the pharmaceutical industry restore its broken image? /
title_full Devalued and distrusted [electronic resource] : can the pharmaceutical industry restore its broken image? / John L. LaMattina.
title_fullStr Devalued and distrusted [electronic resource] : can the pharmaceutical industry restore its broken image? / John L. LaMattina.
title_full_unstemmed Devalued and distrusted [electronic resource] : can the pharmaceutical industry restore its broken image? / John L. LaMattina.
title_auth Devalued and distrusted can the pharmaceutical industry restore its broken image? /
title_new Devalued and distrusted
title_sort devalued and distrusted can the pharmaceutical industry restore its broken image? /
publisher Wiley,
publishDate 2013
physical ix, 125 p. : col. ill.
contents Machine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts.
isbn 9781118511299 (electronic bk.)
callnumber-first H - Social Science
callnumber-subject HD - Industries, Land Use, Labor
callnumber-label HD9665
callnumber-sort HD 49665.5 L36 42013
genre Electronic books.
genre_facet Electronic books.
url https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1104475
illustrated Illustrated
dewey-hundreds 300 - Social sciences
dewey-tens 330 - Economics
dewey-ones 338 - Production
dewey-full 338.4/76151
dewey-sort 3338.4 576151
dewey-raw 338.4/76151
dewey-search 338.4/76151
oclc_num 823389919
work_keys_str_mv AT lamattinajohnl devaluedanddistrustedcanthepharmaceuticalindustryrestoreitsbrokenimage
AT proquestfirm devaluedanddistrustedcanthepharmaceuticalindustryrestoreitsbrokenimage
status_str n
ids_txt_mv (MiAaPQ)5001104475
(Au-PeEL)EBL1104475
(CaPaEBR)ebr10641813
(CaONFJC)MIL422992
(OCoLC)823389919
is_hierarchy_title Devalued and distrusted can the pharmaceutical industry restore its broken image? /
author2_original_writing_str_mv noLinkedField
_version_ 1792330742419685376
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02530nam a2200373 a 4500</leader><controlfield tag="001">5001104475</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">121010s2013 njuad sb 001 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2012032915</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781118487471 (pbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118511299 (electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5001104475</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL1104475</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10641813</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL422992</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)823389919</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">HD9665.5</subfield><subfield code="b">.L36 2013</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">338.4/76151</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">LaMattina, John L.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Devalued and distrusted</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">can the pharmaceutical industry restore its broken image? /</subfield><subfield code="c">John L. LaMattina.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Hoboken, N.J. :</subfield><subfield code="b">Wiley,</subfield><subfield code="c">2013.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">ix, 125 p. :</subfield><subfield code="b">col. ill.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Machine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&amp;D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&amp;D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"While the pharmaceutical industry can play an important role in converting the knowledge generated by the Human Genome Project into new medicines, it also faces a popular perception that it is simply out to make money by promoting unsafe medicines to an unsuspecting public. Written by former Pfizer president John LaMattina, this book addresses the progress that the industry has made in improving its abilities to measure both the risk and benefits of its new medicines, where the industry should invest its R&amp;D resources, and how the industry can rehabilitate its image. Essential reading for pharmaceutical executives and professionals"--</subfield><subfield code="c">Provided by publisher.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Corrupt practices.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1104475</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>

Similar Items